Lountos George T, Cherry Scott, Tropea Joseph E, Waugh David S
Basic Science Program, Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA.
Macromolecular Crystallography Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, MD 21702, USA.
Acta Crystallogr F Struct Biol Commun. 2015 Feb;71(Pt 2):199-205. doi: 10.1107/S2053230X15000217. Epub 2015 Jan 28.
4-Nitrophenyl phosphate (p-nitrophenyl phosphate, pNPP) is widely used as a small molecule phosphotyrosine-like substrate in activity assays for protein tyrosine phosphatases. It is a colorless substrate that upon hydrolysis is converted to a yellow 4-nitrophenolate ion that can be monitored by absorbance at 405 nm. Therefore, the pNPP assay has been widely adopted as a quick and simple method to assess phosphatase activity and is also commonly used in assays to screen for inhibitors. Here, the first crystal structure is presented of a dual-specificity phosphatase, human dual-specificity phosphatase 22 (DUSP22), in complex with pNPP. The structure illuminates the molecular basis for substrate binding and may also facilitate the structure-assisted development of DUSP22 inhibitors.
4-硝基苯磷酸酯(对硝基苯磷酸酯,pNPP)在蛋白质酪氨酸磷酸酶的活性测定中被广泛用作小分子磷酸酪氨酸样底物。它是一种无色底物,水解后会转化为黄色的4-硝基酚离子,可通过在405nm处的吸光度进行监测。因此,pNPP测定已被广泛用作评估磷酸酶活性的快速简便方法,也常用于筛选抑制剂的测定中。本文展示了双特异性磷酸酶人双特异性磷酸酶22(DUSP22)与pNPP复合物的首个晶体结构。该结构阐明了底物结合的分子基础,也可能有助于DUSP22抑制剂的结构辅助开发。